Amerise Biosciences Complete Financial Statements
AMERISE • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Amerise Biosciences (AMERISE).
Downloads include all available records across all periods.
For market performance, see the
AMERISE stock price today
.
Profitability Ratios
Net Profit Margin
10.00%
2022 data
EBITDA Margin
10.00%
2022 data
Return on Assets
11.11%
2022 data
Return on Equity
20.00%
2022 data
Balance Sheet Ratios
Debt to Equity
1.80
2022 data
Equity Ratio
55.56%
2022 data
Asset Turnover
1.11
2022 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Assets Growth
+80.0%
Year-over-Year
Liabilities Growth
+80.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 0.00 | -0.02 | -0.02 | 0.08 | -0.05 | -0.02 | 0.00 | 0.00 | -0.14 | 0.00 | -0.01 |
Related Pages for Amerise Biosciences
Additional stock information and data for AMERISE
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 9 | 5 | 6 | 12 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Current Assets | 0 | 0 | 0 | 6 | 0 | 0 | 5 | 3 | 3 | 0 | 4 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2 | 2 | 5 | 5 | 3 | 5 | 1 | 2 | 2 | 0 | 3 |
| Other Assets | 6 | 3 | 1 | 7 | 3 | 1 | 5 | 3 | 3 | 7 | 4 |
| LIABILITIES | |||||||||||
| Total Liabilities | 9 | 5 | 6 | 12 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 5 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 7 | 7 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 | 0 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 0 | 0 | 0 | 0 | 5 | -2 | 0 | -4 | 1 | 0 |
| Investing Activities | -3 | 0 | 0 | 0 | 0 | -5 | 2 | 0 | 4 | -1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |